Medical weight loss built for midlife bodies

Why weight gets harder after 40

Several changes stack up in midlife. Muscle mass tends to decline unless you train against it, and less muscle means fewer calories burned at rest. Insulin sensitivity often falls. For women, the menopause transition shifts where fat is stored, often toward the abdomen. Sleep becomes lighter, which affects appetite hormones and food choices. Medications for blood pressure, mood or sleep can add weight too.

None of this means weight loss is out of reach. It means the plan needs to account for what has changed, which is why we start by looking at your labs, your medications and your history.

How HealifyMD approaches weight care

• Assess: a licensed clinician reviews your history, current medications and goals.
• Measure: baseline labs such as glucose, A1c, lipids, kidney and liver function, and thyroid as needed.
• Plan: medication when appropriate, plus targets for protein, strength training and sleep.
• Adjust: dose changes are gradual and based on how you tolerate treatment and how you progress.
• Maintain: a plan for what happens after the initial loss, including whether and how to taper.

GLP-1 medication options

GLP-1 medications act on hormones that regulate appetite and blood sugar, slowing stomach emptying and helping you feel full on less food. Tirzepatide also acts on a second hormone receptor, GIP. Branded versions, Wegovy (semaglutide) and Zepbound (tirzepatide), are FDA-approved for long-term weight management in adults with a BMI of 30 or higher, or 27 or higher with a weight-related condition.

HealifyMD clinicians may prescribe compounded semaglutide (injection from $299/month; oral capsules $299/month) or compounded tirzepatide (injection from $399/month; oral capsules $399/month). Compounded GLP-1 medications are not FDA-approved, the FDA does not review them for safety, effectiveness or quality, and they are not the same as Wegovy or Zepbound. Results from the branded drugs' trials do not automatically apply to compounded versions. If you already take a branded GLP-1 through your own pharmacy benefit, our Weight Loss Program Membership (from $75/month) provides clinical support around it.

Safety points to know before starting

• Stomach side effects are common, especially early and after dose increases: nausea, vomiting, diarrhea, constipation and heartburn.
• Semaglutide and tirzepatide carry a boxed warning about thyroid C-cell tumors seen in rodents. They should not be used if you or a family member has had medullary thyroid cancer or if you have MEN 2.
• Get urgent care for severe, persistent abdominal pain that may spread to the back, which can signal pancreatitis.
• Gallbladder problems can occur, particularly with rapid weight loss.
• These medications are not for use during pregnancy. Plan with your clinician if you might become pregnant, since stopping ahead of a planned pregnancy is advised.
• With compounded injections, measure doses exactly as instructed; the FDA has received reports of hospitalizations tied to dosing errors.

Protecting muscle while you lose fat

Rapid weight loss can include lean mass along with fat, and midlife adults have less muscle to spare. Your plan will emphasize adequate protein spread across meals, resistance training two or more times a week and enough sleep to recover. These habits also help you keep the weight off if you later reduce or stop medication.

Other medications your clinician may consider

GLP-1 medication is not the only tool. For some people with prediabetes or insulin resistance, a clinician may consider metformin ($149 for 3 months, or $50/month), an FDA-approved diabetes medication that is sometimes used off-label to support weight management. A continuous glucose monitor ($189 for one 14-day sensor, clinician visit included) can show how your blood sugar responds to meals, sleep and exercise, which some people find useful when adjusting habits.

For women in perimenopause or menopause, weight change often overlaps with hormone changes, sleep disruption and hot flashes. If those symptoms are part of the picture, it may make sense to look at hormone therapy as well. Weight loss and hormone care can be coordinated in a single plan.

What progress looks like

Progress is not just the number on the scale. Your clinician will look at waist measurements, energy, blood sugar and lipid markers, blood pressure and how well you are tolerating treatment. People respond differently, and some do not respond enough to justify continuing. Federal guidance notes that if you have not lost at least 5% of your starting weight after 12 weeks at the full dose, stopping is usually advised.